Crossmark Global Holdings Inc. lowered its stake in Plexus Corp. (NASDAQ:PLXS - Free Report) by 48.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,069 shares of the technology company's stock after selling 1,908 shares during the period. Crossmark Global Holdings Inc.'s holdings in Plexus were worth $324,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of the company. Quarry LP lifted its stake in shares of Plexus by 573.5% in the 3rd quarter. Quarry LP now owns 229 shares of the technology company's stock valued at $31,000 after purchasing an additional 195 shares during the period. USA Financial Formulas bought a new stake in Plexus in the fourth quarter valued at approximately $56,000. Point72 DIFC Ltd acquired a new stake in Plexus in the third quarter worth $51,000. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Plexus during the third quarter worth $55,000. Finally, Farther Finance Advisors LLC grew its holdings in shares of Plexus by 89.4% in the 3rd quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company's stock valued at $63,000 after buying an additional 219 shares during the period. Institutional investors and hedge funds own 94.45% of the company's stock.
Insider Activity at Plexus
In other Plexus news, insider Victor (Pang Hau) Tan sold 3,000 shares of the company's stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $165.90, for a total transaction of $497,700.00. Following the sale, the insider now directly owns 5,605 shares of the company's stock, valued at approximately $929,869.50. This represents a 34.86 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Todd P. Kelsey sold 1,500 shares of Plexus stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $156.39, for a total transaction of $234,585.00. Following the completion of the transaction, the chief executive officer now directly owns 74,271 shares of the company's stock, valued at approximately $11,615,241.69. This trade represents a 1.98 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 29,046 shares of company stock valued at $4,655,870. 1.76% of the stock is owned by insiders.
Analyst Ratings Changes
PLXS has been the topic of several recent analyst reports. Benchmark reiterated a "buy" rating and set a $165.00 target price on shares of Plexus in a report on Wednesday, January 22nd. KeyCorp initiated coverage on Plexus in a research report on Tuesday, October 22nd. They issued a "sector weight" rating for the company. Stifel Nicolaus raised their target price on shares of Plexus from $136.00 to $150.00 and gave the stock a "hold" rating in a report on Tuesday, December 10th. StockNews.com upgraded shares of Plexus from a "hold" rating to a "buy" rating in a report on Monday, November 18th. Finally, Needham & Company LLC raised their price objective on shares of Plexus from $162.00 to $172.00 and gave the stock a "buy" rating in a report on Friday. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat.com, Plexus presently has a consensus rating of "Moderate Buy" and an average price target of $162.33.
View Our Latest Stock Report on Plexus
Plexus Stock Down 5.9 %
NASDAQ PLXS traded down $8.94 during trading on Monday, hitting $143.55. The stock had a trading volume of 270,877 shares, compared to its average volume of 180,661. The company has a market capitalization of $3.89 billion, a PE ratio of 33.31 and a beta of 0.91. Plexus Corp. has a 12 month low of $90.18 and a 12 month high of $172.89. The company's 50-day moving average price is $162.03 and its two-hundred day moving average price is $142.46. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.71 and a current ratio of 1.51.
Plexus (NASDAQ:PLXS - Get Free Report) last announced its earnings results on Wednesday, January 22nd. The technology company reported $1.49 EPS for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a return on equity of 10.43% and a net margin of 3.03%. As a group, sell-side analysts forecast that Plexus Corp. will post 6.13 EPS for the current year.
About Plexus
(
Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
See Also
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.